Pregnant women are physiologically at higher risk of severe influenza than the general adult population. The changes that protect the fetus from immune rejection, the rising progesterone, the upward pressure of the uterus on the diaphragm in later pregnancy, and the increased cardiac workload all combine to make the lungs and heart less able to cope with the stress of a flu infection. Indian and international data show that pregnant women who catch flu are several times more likely to be hospitalised, to develop pneumonia, and rarely to die from flu complications than non-pregnant women of the same age.

The inactivated influenza vaccine reduces the risk of flu in the mother by roughly fifty percent across the flu season, and importantly reduces the risk of severe flu (hospitalisation, pneumonia, ICU admission) by even more. The benefit holds across all trimesters and is meaningful in the Indian flu season which runs from October through March with monsoon and winter peaks.

The second major benefit is for the baby. Maternal antibodies generated by the vaccine cross the placenta in the second and third trimesters and protect the newborn for the first six months of life, which is exactly the period when the baby is too young for their own flu vaccine and most vulnerable to severe flu. This passive antibody protection is one of the strongest reasons FOGSI recommends the shot in every pregnancy.

The inactivated influenza vaccine has one of the strongest safety records of any vaccine used in pregnancy. The World Health Organization recommends it for all pregnant women in any trimester as a priority group. The American College of Obstetricians and Gynecologists (ACOG) and the Federation of Obstetric and Gynaecological Societies of India (FOGSI) issue the same recommendation, supported by ICMR guidance.

Millions of pregnant women have received the shot across the past two decades and large studies consistently show no increased risk of miscarriage, no increased risk of birth defects, no increased risk of preterm birth, and no increased risk of low birth weight. On the contrary, vaccinated pregnancies show slightly lower rates of preterm birth and low birth weight, likely because they avoid the severe flu illness that itself raises those risks.

The vaccine used in pregnancy is the inactivated injectable form (it contains killed virus particles or only purified surface proteins) and cannot cause influenza. The live attenuated nasal-spray vaccine, used in some countries for children and healthy adults, is not given in pregnancy and is not commonly available in India in any case.

The ideal time to take the flu shot is at the start of the Indian flu season, which means October or November each year before the winter peak. The vaccine takes about two weeks to build full protection, so a shot taken in October gives good cover for the November to March higher-risk months. Many parts of India also see a monsoon flu uptick in July and August, and a shot taken earlier in the year still provides cover.

Any trimester is acceptable for the flu shot. It is safe in the first trimester (so do not delay if the season is starting and you are early in pregnancy), and it is equally safe in the second and third trimesters. If you become pregnant during the flu season, take the shot at the next antenatal visit rather than waiting.

If you reached the end of pregnancy without receiving the flu shot, take it in the immediate postpartum period (even while breastfeeding) — this still protects you and passes some antibodies to the baby through breast milk, and protects the baby indirectly by reducing the chance that you bring flu home.

The flu vaccines commonly available in India for pregnant women are inactivated injectable vaccines, given as a single intramuscular shot in the upper arm. Common brands include Vaxigrip Tetra (Sanofi, a quadrivalent vaccine covering four influenza strains), Influvac Tetra (Abbott, also quadrivalent), and Fluvac and IIVac (Indian manufacturers), with newer egg-free options available for women with severe egg allergy.

All of these inactivated formulations are considered safe for pregnant women in any trimester and are the type recommended by FOGSI. The quadrivalent (four-strain) vaccines are the current standard and cover the influenza A and B strains predicted to circulate in the season.

The live attenuated nasal-spray flu vaccine (sold abroad as FluMist) is not recommended in pregnancy because it contains weakened live virus, and in India it is not routinely available, so there is little practical risk of getting the wrong type by mistake. If in doubt, ask the clinic to confirm the brand is an inactivated injectable before the shot.

The flu shot is mostly delivered through private channels in India. Private hospitals and clinics including Apollo Cloudnine Max Healthcare Fortis Manipal and Cradle typically charge between eight hundred and two thousand rupees per dose, with the higher end for the quadrivalent imported brands and the lower end for Indian manufacturers. Standalone vaccination clinics, paediatric clinics that also offer adult vaccines, and many pharmacies (especially in metros) offer the same shot at similar prices.

Government provision is limited. The flu shot is not part of the universal Mission Indradhanush antenatal vaccine schedule, although primary health centres (PHCs) and district hospitals sometimes offer it free or at low cost to high-risk pregnant women under Janani Suraksha Yojana or state-specific schemes, particularly during flu outbreaks. The Tdap (TT booster) is the universally free antenatal vaccine; the flu shot usually needs to be paid for privately.

Practical tip: book the flu shot at the same visit as a routine antenatal check or growth scan at your usual hospital to avoid an extra trip, and ask the OB to add it to the antenatal plan in October so it is not forgotten.

One of the strongest reasons to take the flu shot in pregnancy is the protection it gives the baby in the first six months of life. Maternal antibodies generated by the vaccine cross the placenta in the second and third trimesters and circulate in the baby's bloodstream after birth, providing real protection against influenza for roughly the first six months.

This matters because the baby cannot receive their own flu vaccine until six months of age, and infants under six months are at the highest risk of severe flu, hospitalisation and rarely death from flu in their age group. The mother's vaccination is currently the only effective way to protect the newborn in this window.

This protection is especially important for babies expected to be born in or near the flu season (roughly September to March deliveries in India), and for babies in joint-family or crèche settings where flu exposure is higher. The vaccine antibodies also continue to pass in small amounts through breast milk, adding a further layer of protection during breastfeeding.

The flu shot is one of the most well-tolerated vaccines. The most common side effect is soreness redness or mild swelling at the injection site in the upper arm, usually lasting one to two days and easily managed with a cold compress and paracetamol if needed. A small bruise is normal.

Some women feel mildly off-colour for a day or two after the shot with low-grade fever mild body ache and tiredness. This is the immune system responding to the vaccine and is not flu illness — the inactivated vaccine contains killed virus or only surface proteins and cannot cause influenza. Rest fluids and paracetamol manage these symptoms in a day or two.

Serious allergic reaction (anaphylaxis) is rare, with the strongest risk being severe egg allergy because most flu vaccines are made in eggs. Egg-free formulations are now available for women with a history of anaphylaxis to eggs. Clinics observe pregnant women for fifteen to thirty minutes after the shot to manage any reaction promptly.

The list of true contraindications is short. A history of severe anaphylaxis to a previous flu shot is a clear reason to avoid the same vaccine, although the OB may consider a different brand or formulation under specialist supervision. A history of Guillain-Barre syndrome within six weeks of a previous flu shot is a relative contraindication that needs a specialist discussion.

Severe egg allergy with anaphylaxis was previously a reason to avoid the shot, but egg-free formulations such as recombinant flu vaccines are now available and most women with egg allergy can still be safely vaccinated under supervision. Discuss the allergy history with the OB or vaccination clinic before booking.

If you have a fever or active illness on the day of the shot, the vaccination is usually postponed by a few days until you have recovered, so the body's immune response is not divided. A mild cold or runny nose without fever is not a reason to delay.

The Tdap vaccine (which covers tetanus diphtheria and pertussis, the latter being whooping cough) is the other key vaccine in pregnancy and is recommended by FOGSI between twenty-seven and thirty-six weeks of pregnancy in every pregnancy. The flu shot and Tdap can be given at the same visit in different arms with no loss of effectiveness for either.

If the timing does not line up exactly, take the flu shot when the flu season starts (October to November) and the Tdap during the recommended twenty-seven to thirty-six week window, even if they fall on different visits. Both are recommended in every pregnancy regardless of whether you had them in a previous pregnancy.

Other inactivated vaccines such as hepatitis B and COVID-19 boosters can also be given in pregnancy when indicated and can usually be combined with the flu shot. Live vaccines such as MMR and varicella are not given in pregnancy and should be planned before conception or after delivery.

The inactivated flu vaccine is fully safe during breastfeeding, and is in fact strongly recommended postpartum if you did not receive it during pregnancy. There is no risk of transmitting the vaccine to the baby through breast milk, and the vaccine does not affect milk supply.

On the contrary, vaccinating a breastfeeding mother provides a small extra protective benefit to the baby because some vaccine-induced antibodies pass into breast milk and add to the baby's defences. The protection is modest compared with the antenatal antibody transfer across the placenta but is still useful.

The flu shot in the postpartum period also reduces the chance that the mother brings flu home to a newborn who cannot yet be vaccinated. Many private hospitals and paediatric clinics offer the shot during routine postnatal visits or the baby's vaccination appointments, making it easy to schedule.